Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

30.0%

% of XPH's 40 holdings also in PPH

52.2%

% of PPH's 26 holdings also in XPH

Overlap by Weight
Sector Drift (XPH minus PPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XPH
Weight
in PPH
Overlap
ELI LILLY & CO 4.3% 13.8% 4.3%
JOHNSON & JOHNSON 4.1% 7.2% 4.1%
ZOETIS INC 3.9% 4.7% 3.9%
PFIZER INC 3.7% 4.4% 3.7%
MERCK & CO. INC. 3.6% 4.8% 3.6%

Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PPH
CORCEPT THERAPEUTICS INC 4.8%
TARSUS PHARMACEUTICALS, INC. 4.2%
ROYALTY PHARMA PLC CLASS A 4.2%
PRESTIGE BRANDS HOLDINGS INC 3.9%
PACIRA PHARMACEUTICALS INC 3.2%
PERRIGO CO 3.0%
ARVINAS, INC. 2.8%
HARMONY BIOSCIENCES HOLDINGS, INC. 2.8%
AXSOME THERAPEUTICS, INC. 2.6%
ELANCO ANIMAL HEALTH, INC. 2.5%
XPH Underweight Relative to PPH
ELI LILLY & CO -9.4%
ABBVIE INC -6.3%
NOVARTIS AG-ADR -5.8%
CENCORA INC -5.8%
MCKESSON CORP -5.6%
ASTRAZENECA PLC-SPONS ADR -5.1%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS -5.1%
SANOFI-AVENTIS-ADR -5.0%
GLAXOSMITHKLINE PLC-SPON ADR -4.8%
NOVO-NORDISK A/S-SPONS ADR -4.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY